drugset / Trial / NCT01850446

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

NCT01850446

Phase 4 Completed 184 enrolled Materia Medica Holding
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is: * to assess the efficacy of Ergoferon in treatment of influenza; * to assess the safety of Ergoferon in treatment of influenza; * to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.

Timeline

Start
2015-02-20
Primary completion
2018-04-16
Completion
2018-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergoferon Protein / enzyme biologic Oral
Comparator Oseltamivir Small molecule 75 mg Oral

Indications